213 related articles for article (PubMed ID: 21511863)
1. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.
Mangla R; Kolar B; Zhu T; Zhong J; Almast J; Ekholm S
AJNR Am J Neuroradiol; 2011; 32(6):1004-10. PubMed ID: 21511863
[TBL] [Abstract][Full Text] [Related]
2. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Xing Z; You RX; Li J; Liu Y; Cao DR
Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.
Wang S; Kim S; Chawla S; Wolf RL; Knipp DE; Vossough A; O'Rourke DM; Judy KD; Poptani H; Melhem ER
AJNR Am J Neuroradiol; 2011 Mar; 32(3):507-14. PubMed ID: 21330399
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Primary Central Nervous System Lymphoma and High-Grade Glioma with Dynamic Susceptibility Contrast-Derived Metrics: Pilot Study.
Chaganti J; Taylor M; Woodford H; Steel T
World Neurosurg; 2021 Jul; 151():e979-e987. PubMed ID: 34020062
[TBL] [Abstract][Full Text] [Related]
6. Investigating dynamic susceptibility contrast-enhanced perfusion-weighted magnetic resonance imaging in posterior fossa tumors: differences and similarities with supratentorial tumors.
Gaudino S; Benenati M; Martucci M; Botto A; Infante A; Marrazzo A; Ramaglia A; Marziali G; Guadalupi P; Colosimo C
Radiol Med; 2020 Apr; 125(4):416-422. PubMed ID: 31916104
[TBL] [Abstract][Full Text] [Related]
7. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
Cindil E; Sendur HN; Cerit MN; Dag N; Erdogan N; Celebi FE; Oner Y; Tali T
Neuroradiology; 2021 Mar; 63(3):331-342. PubMed ID: 32821962
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of enhancement-perfusion mismatch in differentiation of CNS lymphomas from other enhancing malignant tumors of the brain.
Goyal P; Kumar Y; Gupta N; Malhotra A; Gupta S; Gupta S; Mangla M; Mangla R
Quant Imaging Med Surg; 2017 Oct; 7(5):511-519. PubMed ID: 29184763
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric analysis from dynamic susceptibility contrast-enhanced perfusion MRI to evaluate malignant brain tumors.
Abreu VS; Tarrio J; Silva J; Almeida F; Pinto C; Freitas D; Filipe JP
J Neuroimaging; 2024; 34(2):257-266. PubMed ID: 38173078
[TBL] [Abstract][Full Text] [Related]
10. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
12. The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications.
Boxerman JL; Paulson ES; Prah MA; Schmainda KM
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1364-9. PubMed ID: 23413249
[TBL] [Abstract][Full Text] [Related]
13. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
15. The role of dynamic susceptibility contrast-enhanced perfusion MR imaging in differentiating between infectious and neoplastic focal brain lesions: results from a cohort of 100 consecutive patients.
Floriano VH; Torres US; Spotti AR; Ferraz-Filho JR; Tognola WA
PLoS One; 2013; 8(12):e81509. PubMed ID: 24324699
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
17. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
[TBL] [Abstract][Full Text] [Related]
19. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Cha S; Lupo JM; Chen MH; Lamborn KR; McDermott MW; Berger MS; Nelson SJ; Dillon WP
AJNR Am J Neuroradiol; 2007; 28(6):1078-84. PubMed ID: 17569962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]